Diabetes & Vascular Disease Research

Papers
(The median citation count of Diabetes & Vascular Disease Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
The role of high mobility group box-1 on the development of diabetes complications: A plausible pharmacological target45
The association between osteoprotegerin and arterial stiffness in a 10-year longitudinal study of patients with type 2 diabetes42
Corrigendum to “Unraveling the causal role of sleep traits in development of diabetic retinopathy: A UK Biobank observational study and Mendelian randomization”26
Longitudinal profiling and tracking stability in the Singapore study of macro-angiopathy and microvascular reactivity in type 2 diabetes cohort25
Progression of insulin resistance in individuals with type 1 diabetes: A retrospective longitudinal study on individuals from Thailand24
Relationship between non-O blood groups and microvascular risk in type 2 diabetes22
MicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism17
Serum microRNAs: A potential blood-based diagnostic biomarkers for diabetic kidney disease in Emirati patients with type 2 diabetes17
Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus15
RNA-based diagnostic innovations: A new frontier in diabetes diagnosis and management14
Predictive value of lncRNA DBH-AS1 for cardiovascular events in patients with type 2 diabetes mellitus with coronary heart disease13
Sensory testing in type 2 diabetes: Insights into neuropathy and systemic complications12
Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study12
Disruption of COMMD1 accelerates diabetic atherosclerosis by promoting glycolysis12
Coronary artery calcium score and coronary computed tomography angiography predict one-year mortality in patients with type 2 diabetes and peripheral artery disease undergoing partial foot amputation11
High serum Bhlhe40 levels are associated with subclinical atherosclerosis in patients with type 2 diabetes mellitus: A cross-sectional study11
“Arterial stiffness is not associated with changes in the circadian pattern of blood pressure in patients with type 1 diabetes mellitus and cardiovascular autonomic dysfunction”11
Molecular mechanisms of diabetic heart disease: Insights from transcriptomic technologies10
Hemoglobin A1c association patterns with cardiovascular outcomes among patients with diabetes mellitus following percutaneous coronary intervention: A systematic review10
Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes10
Lipoprotein (a) as a predictor of diabetic retinopathy in patients with type 2 diabetes: A systematic review10
Association of hemoglobin glycation index with prognosis of coronary artery disease after percutaneous coronary intervention: A retrospective cohort study10
Trends in cardiovascular burden and mortality among adults with prediabetes in the US, 1999–20189
TyG-BMI and hypertension in Normoglycemia subjects in Japan: A cross-sectional study9
Ten-year incidence of post-transplant Diabetes Mellitus in renal transplant patients9
Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study9
Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure9
Temporal trends in minor and major lower extremity amputation in people with type 2 diabetes: The Fremantle Diabetes Study8
Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial7
The association between hypoglycemia and panvascular disease in type 2 diabetes patients: The correlation structure mediated by inflammatory and metabolic abnormalities6
Body composition rather than liver fat associates with carotid Intima–Media thickness in youth with type 1 diabetes6
The triglyceride-glucose index and mortality in chronic kidney and cardiovascular disease patients: A cohort study6
Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease6
Visceral adipose tissue accumulation and risk of organ complications among individuals with type 2 diabetes mellitus: A two-sample Mendelian randomization study6
Subclinical myocardial dysfunction in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus: Associations with Endothelin-1, E-selectin, and Endocan5
Letter to editor: Comments on “Early diagnosis value of lncRNA SNHG14 combined with miR-493-5p in gestational diabetes mellitus and its correlation with pregnancy outcome”5
A cross-sectional study exploring the relationship between oxidative balance score and 10-year atherosclerotic cardiovascular disease risk based on the National Health and Nutrition Examination Survey5
Comparison of drug-coated balloons and plain old balloon angioplasty in hemodialysis patients with Below-The-Knee artery disease5
A novel approach to diabetes-related foot ulcers/disease: First report of bipolar conventional RF lumbar sympathetic block5
Association between SGLT2 inhibitors and recurrence of cerebrovascular events in patients with type 2 diabetes: A population-based cohort study5
US eligibility and preventable cardiovascular disease events from semaglutide in type 2 diabetes5
miR-1187 induces podocyte injury and diabetic nephropathy through autophagy5
Predictive power of isolated high home systolic blood pressure for cardiovascular outcomes in individuals with type 2 diabetes mellitus: KAMOGAWA-HBP study4
Sex differences in cardiovascular disease risk in type 1 diabetes: The vascular bed paradox in women4
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis4
Glycemic control and outcome after carotid intervention in patients with T2D: A Swedish nationwide cohort study4
Bioinformatics analyses of potential microRNAs and their target genes in myocardial infarction patients with diabetes4
Early diagnosis value of lncRNA SNHG14 combined with miR-493-5p in gestational diabetes mellitus and its correlation with pregnancy outcome4
Responses of retinal and brain microvasculature to streptozotocin induced diabetes revealed by global expression profiling4
Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort3
A novel multi-omics–machine learning pipeline reveals immune and metabolic links between type 2 diabetes and atherosclerosis3
Comparative prognostic value of hemoglobin glycation index and glycation gap for mortality risk in adults: A population-based study3
Combined effect of body mass index and atherogenic index of plasma on risk of stroke among individuals with abnormal glucose metabolism: Evidence from the China health and retirement longitudinal stud3
Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome3
Predictors of coronary artery calcium burden in asymptomatic patients with newly diagnosed type 2 diabetes mellitus3
Restoration of coronary microvascular function by OGA overexpression in a high-fat diet with low-dose streptozotocin-induced type 2 diabetic mice3
Type 1 diabetes mellitus disease burden in high health expenditure countries between 1990 and 20193
Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists3
Associations of prognostic nutritional index with risk of all-cause and cardiovascular disease mortalities in persons with gestational diabetes mellitus: A NHANES-based analysis2
Prevalence and risk factors of retinal vein occlusion in individuals with diabetes: The kailuan eye study2
Analysis of the diabetic arterial transcriptome to define novel biomarkers of macrovascular disease2
The impact of semaglutide on wound healing in diabetes related foot ulcer patients: A TriNetX database study2
Insights on accelerometer-measured 24-hour movement behaviour across type 2 diabetes sub-phenotypes in the Asian population2
Corrigendum to “A novel approach to diabetes-related foot ulcers/disease: First report of bipolar conventional RF lumbar sympathetic block”2
Effect of colchicine for secondary prevention of cardiovascular diseases in individuals with diabetes: A meta-analysis of randomized trials2
MiR-143-3p serves as a novel biomarker for diabetic cardiomyopathy and is involved in regulating high glucose-induced cardiomyocyte injury2
Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial2
Impact of blood glucose control on clinical outcomes in type 2 diabetes patients hospitalized with COVID-19 infection2
Impact of diabetes on outcomes of cardiogenic shock: A systematic review and meta-analysis2
0.030081987380981